登入 加入會員 求助
 
Changchun Changsheng Life Sciences Ltd.
 
 
Recommended Results 
 
Clinical Rabies Vaccine For Human Use 

  產品分類 : 化學->化學用品->aspalthic products

     
Clinical Rabies Vaccine For Human Use
       

  產品規格
 
Model No:    0.5ml /syringe
  Country  CN
  Minimum Order  5000
  Payment Term  L/C,T/T

 

  產品描述
   
  <p class="MsoNormal">
<span>
<p class="MsoNormal">
Rabies vaccine is a freeze-dried preparation made&nbsp;from the inactivated rabies fixed virus. The virus&nbsp;grows in Vero cells. After cultivation, harvest&nbsp;and concentration, the virus suspension is inactivated, purified and then lyophilized to make the&nbsp;vaccine after the addition of a suitable stabilizer. &nbsp;It&nbsp;is used to prevent rabies.
</p>
<br />
</span>
</p>
<p class="MsoNormal">
<span>If a person is bitten or scratched by a rabid dog or other rabid animals, regardless of age or sex, the wounds shall be cleaned immediately (flush the wounds repeatedly with clean water or soup water, followed by applying iodine tincture or ethanol for several times), and the exposed person shall be inoculated with the vaccine according to the post-exposure schedule as soon as possible. The person at risk of contacting rabies virus (such as veterinarians, animal breeders, forestry workers, workers in slaughterhouse and staffs in rabies laboratory) shall be immunized following the pre-exposure treatment schedule.</span>
</p>
<p class="MsoNormal">
<span><br />
</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Function and use<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
The preparation can induce immunity against rabies virus in recipients following immunization. It is used to prevent rabies in human.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Specifications<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose. The potency of the vaccine shall be not less than 2.5 IU.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<br />
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<p class="MsoNormal">
[Diluent of Vaccine]
</p>
<p class="MsoNormal">
Sterile water for injection used as the diluent shall comply with the specifications set&nbsp;forth in Volume II&nbsp;of the Chinese Pharmacopoeia.
</p>
<p class="MsoNormal">
[Control tests on final product]
</p>
<p class="MsoNormal">
Other than the determination of the moisture content,the enclosed sterile water for injection shall be added into the final product as the stated value,and the reconstitude product shall be subjected to the following tests.
</p>
<p class="MsoNormal">
&nbsp; Identity test
</p>
<p class="MsoNormal">
Rabies viral antigen in the tese sample shall be demonstrated with ELISA.
</p>
<p class="MsoNormal">
&nbsp;Apperance
</p>
<p class="MsoNormal">
The product looks like a white crisp cake.After reconstitution,it shall turn into transparent liquid free from foreign matters.
</p>
<p class="MsoNormal">
&nbsp;Chemical tests
</p>
<p class="MsoNormal">
&nbsp; &nbsp;pH
</p>
<p class="MsoNormal">
The pH shall be 7. 2-8. 0 (Appendix V A).
</p>
<p class="MsoNormal">
&nbsp; Moisture content
</p>
<p class="MsoNormal">
The content of residual moisture shall be not more&nbsp;than 3. 0% (Appendix&nbsp;XII&nbsp;D).
</p>
<p class="MsoNormal">
&nbsp;Potency test
</p>
<p class="MsoNormal">
The potency of the vaccine shall be not less than&nbsp;2. 5 IU/dose (Appendix XI A).
</p>
<p class="MsoNormal">
&nbsp; Thermostability test
</p>
<p class="MsoNormal">
Before release each lot of vaccine shall be subjected&nbsp;to thermostability test. &nbsp;The test sample is&nbsp;exposed&nbsp;at 37℃for 28 days for the determination of&nbsp;potency (Section 3. 4. 4) . &nbsp;The test vaccine which&nbsp;passed the thermostability test is considered&nbsp;satisfactory in potency test.
</p>
<p class="MsoNormal">
&nbsp;Test for residual bovine serum albumin
</p>
<p class="MsoNormal">
The content of residual bovine&nbsp;serum albumin shall&nbsp;be not more than 50 µg/does (Appendix&nbsp;XIII&nbsp;I).
</p>
<p class="MsoNormal">
&nbsp;Test for the content of residual antibiotics
</p>
<p class="MsoNormal">
Test for the content of residual antibiotics shall be&nbsp;carried out if antibiotics have been added during the&nbsp;production. The residual antibiotic content shall&nbsp;be not more than 50 ng/dose determined by&nbsp;ELISA.
</p>
<p class="MsoNormal">
&nbsp;Test for residual DNA of Vero cells
</p>
<p class="MsoNormal">
The residual DNA of Vero cells shall be not more&nbsp;than 100 pg/dose (Appendix IX B, method l).
</p>
<p class="MsoNormal">
&nbsp;Test for residual protein of Vero cells
</p>
<p class="MsoNormal">
The residual protein of Vero cells shall be not more&nbsp;than 4 µg/dose by ELISA.
</p>
<p class="MsoNormal">
&nbsp; Sterility test
</p>
<p class="MsoNormal">
It complies with the test for sterility (Appendix XII&nbsp;A) .
</p>
<p class="MsoNormal">
&nbsp; Test for abnormal
</p>
<p class="MsoNormal">
It complies with the test&nbsp;(Appendix&nbsp;XII&nbsp;F).
</p>
<p class="MsoNormal">
&nbsp;Test for bacterial endotoxin
</p>
<p class="MsoNormal">
The content of bacterial endotoxin shall be not more than 50EU/does.(Appendix XII&nbsp;E, gel-clot limit test).
</p>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<span>[</span>Feature<span>]</span>
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
&nbsp;1. High potency at least 4.0IU/dose
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
&nbsp;2. Perfect stability,&nbsp;3-years shelf life
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
&nbsp;3. Fine purification above 99%.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
&nbsp;4. No serious adverse reaction.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
&nbsp;5. Medium can be controlled effectively.
</p>
<p class="MsoNormal" style="text-align:justify;" align="justify">
<img src="http://i.bosscdn.com/product/e6/40/1a/52042c3373d7e6bc01c1975301.png@watermark=2&color=I0ZGRkZGRg%3D%3D&type=ZHJvaWRzYW5zZmFsbGJhY2s%3D&size=22&p=5&t=80&text=Y3MtdmFjY2luZS5ib3NzZ29vLmNvbQ%3D%3D" title="rabies" alt="rabies" />
</p>
<p>
<br />
</p>ccls-vaccine.com

  其他類似產品
 
Medical Influenza Vaccine(Split Virion)

Medical Influenza Vaccine(Split Virion)
Clinical hepatitis A vaccine

Clinical hepatitis A vaccine
Lyophilized Meningococcal Polysaccharide Vaccine

Lyophilized Meningococcal Polysaccharide Vaccine
Rabies Vaccine(Vero Cell) Injection

Rabies Vaccine(Vero Cell) Injection
 
   


[ Back Products Catalog ]

Commerce 會員:
請登入您的 帳號 跟 密碼, 系統將自動為您填入您的相關基本資料!
 
帳號:
密碼:
記住我的帳號
 
 
填寫下列表格並寄送詢問函.所有的詢問信函將會自動寄發給你想聯絡的公司
主旨
內容 ﹙ 請勿輸入公司名稱、Email、電話、傳真、網址 ﹚
   

 


公司簡介:

*公司名稱
*E-mail
*國家
*聯絡人
網址
*電話
- -
傳真
- -
*郵遞區號
*城市
*街道地址
*企業形態
批發商   出口商 進口商 製造商
大盤商 零售商  代理商 Retrofitter 使用者
其他, 請詳細說明:
*安全密碼
請輸入所顯示的安全密碼


網站導覽 l 隱私權政策 l 服務團隊 l 合作提案 l 聯絡我們 l 幫幫我 l 廣告刊登 l  B2B商業夥伴
    .